In This Article:
Calix (ASX:CXL) Full Year 2024 Results
Key Financial Results
-
Revenue: AU$24.2m (up 30% from FY 2023).
-
Net loss: AU$25.3m (loss widened by 9.0% from FY 2023).
-
AU$0.14 loss per share (further deteriorated from AU$0.13 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Calix Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 19%. Earnings per share (EPS) also missed analyst estimates by 83%.
The primary driver behind last 12 months revenue was the US segment contributing a total revenue of AU$16.8m (70% of total revenue). Notably, cost of sales worth AU$13.9m amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Research & Development (R&D) costs, amounting to AU$21.4m (44% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of AU$13.5m. Explore how CXL's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Chemicals industry in Australia.
Performance of the Australian Chemicals industry.
The company's shares are down 5.0% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Calix, and understanding this should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.